Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyoscine Bromide for Duration and Pain in Labor
NCT02103166Phase 4Suspended
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Apr 2014
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hyoscine butylbromide, sponsored by Hospital Clínic de Barcelona. Started Apr 2014; status: suspended.
02
Drugs
hyoscine butylbromide
Beyond the preview
Go deeper on NCT02103166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02103166.